Mochi Health vs Fella Health
Two GLP-1 desks, one scoreboard. We put Mochi Health and Fella Health head-to-head on the published Brief Score — the same six factors, scored the same way, no pay-to-win placement.
The verdict
Too close to call on the Brief Score.
Mochi Health and Fella Health are level at 81/100. The scores won't separate them, so the pick comes down to fit: Mochi Health for readers in its served states who want a known consumer brand with a coaching bent. Fella Health for men in one of its ~20 served states who want a male-focused metabolic program.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Mochi Health | Fella Health | |
|---|---|---|
| Brief Score | 81/100 (B−) | 81/100 (B−) |
| Semaglutide | $138/mo | $165/mo |
| Tirzepatide | $238/mo | $399/mo |
| Coverage | 15 states | 20 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
| On the tracker | Stableprice stable | Stableprice stable |
Mochi Health: $138 sema / $238 tirz; footprint capped near 15 states.
Fella Health: $165 sema but $399 tirz — one of the higher tirz lines; ~20 states, no accreditation.
● Not sold on either?
CoreAge Rx tops the whole board at 94/100.
The steadiest desk on the board: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.